Usefulness of p16 INK4a staining for managing histological high-grade squamous intraepithelial cervical lesions

Modern Pathology

Volumn 30, Issue 2, 2017, Pages 304-310

  Miralpeix, Ester ^a   Genovés, Jordi ^a   Solé Sedeño, Josep Maria ^a   Mancebo, Gemma ^a   Lloveras, Belen ^a   Bellosillo, Beatriz ^a   Alameda, Francesc ^a   Carreras, Ramon ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A;

ADULT; ARTICLE; CLINICAL TRIAL; COLPOSCOPY; CYTOLOGY; DIAGNOSTIC TEST ACCURACY STUDY; FOLLOW UP; HISTOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; REMISSION; SQUAMOUS INTRAEPITHELIAL LESION OF THE CERVIX; TREATMENT DURATION; TUMOR BIOPSY; TUMOR CLASSIFICATION; TUMOR GROWTH; TUMOR REGRESSION; ADOLESCENT; CANCER GRADING; DISEASE EXACERBATION; FEMALE; METABOLISM; MIDDLE AGED; PATHOLOGY; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX TUMOR; YOUNG ADULT;

ADOLESCENT; ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOPLASM GRADING; PROSPECTIVE STUDIES; SQUAMOUS INTRAEPITHELIAL LESIONS OF THE CERVIX; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84990954575     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2016.168     Document Type: Article

References (27)

1. Ostör AG. Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol 1993; 12: 186-192
2. Moscicki AB, Ma Y, Wibbelsman C, et al. Rate of and risks for regression of cervical intraepithelial neoplasia 2 in adolescents and young women. Obstet Gynecol 2010; 116: 1373-1380
3. Discacciati MG, de Souza CA, dOtavianno MG, et al. Outcome of expectant management of cervical intraepithelial neoplasia grade 2 in women followed for 12 months. Eur J Obstet Gynecol Reprod Biol 2011; 155: 204-208
4. McAllum B, Sykes PH, Sadler L, et al. Is the treatment of CIN 2 always necessary in women under 25 years old? Am J Obstet Gynecol 2011; 205: e1-e7
5. Arbyn M, Kyrgiou M, Simoens C, et al. Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-Analysis. BMJ 2008; 337: a1284
6. Massad LS, Einstein MH, Huh WK, et al. 2012 ASCCP Consensus Guidelines Conference. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. Obstet Gynecol 2013; 121: 829-846
7. Gage JC, Schiffman M, Hunt WC, et al. Cervical histopathology variability among laboratories: a population-based statewide investigation. Am J Clin Pathol 2013; 139: 330-335
8. Mittal S, Ghosh I, Banerjee D, et al. Reproducibility of cervical intraepithelial neoplasia diagnosis on histological review of cervical punch biopsies from a visual inspection with acetic acid and HPV detection-based screening program. Int J Gynaecol Obstet 2014; 126: 227-231
9. Tsoumpou I, Arbyn M, Kyrgiou M, et al. p16(INK4a) immunostaining in cytological and histological specimens from the uterine cervix: a systematic review and meta-Analysis. Cancer Treat Rev 2009; 35: 210-220
10. Reuschenbach M, Wentzensen N, Dijkstra MG, et al. p16INK4a immunohistochemistry in cervical biopsy specimens: a systematic review and meta-Analysis of the interobserver agreement. Am J Clin Pathol 2014; 142: 767-772
11. Klaes R, Friedrich T, Spitkovsky D, et al. Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 2001; 92: 276-284
12. Giarrè M, Caldeira S, Malanchi I, et al. Induction of pRb degradation by the human papillomavirus type 16 E7 protein is essential to efficiently overcome p16INK4aimposed G1 cell cycle arrest. J Virol 2001; 75: 4705-4712
13. Genovés J, Alameda F, Mancebo G, et al. Human papillomavirus detection and p16INK4a expression in cervical lesions: a comparative study. Hum Pathol 2014; 45: 826-833
14. Darragh TM, Colgan TJ, Thomas Cox J, et al. The lower anogenital squamous terminology standardization project for HPV-Associated lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. Int J Gynecol Pathol 2013; 32: 76-115
15. Negri G, Vittadello F, Romano F, et al. p16INK4a expression and progression risk of low-grade intraepithelial neoplasia of the cervix uteri. Virchows Arch 2004; 445: 616-620
16. del Pino M, Garcia S, Fusté V, et al. Value of p16 (INK4a) as a marker of progression/regression in cervical intraepithelial neoplasia grade 1. Am J Obstet Gynecol 2009; 201: 488
17. Cortecchia S, Galanti G, Sgadari C, et al. Follow-up study of patients with cervical intraepithelial neoplasia grade 1 overexpressing p16Ink4a. Int J Gynecol Cancer 2013; 23: 1663-1669
18. Liao GD, Sellors JW, Sun HK, et al. p16INK4A immunohistochemical staining and predictive value for progression of cervical intraepithelial neoplasia grade 1: a prospective study in China. Int J Cancer 2014; 134: 1715-1724
19. Walker P, Dexeus S, De Palo G, et al. International terminology of colposcopy: an updated report from the International Federation for Cervical Pathology and Colposcopy. Obstet Gynecol 2003; 101: 175-177
20. World Health Organization (WHO). Human Papillomavirus and Related Cancers. Summary Report Update Geneva. WHO: Switzerland, 2010
21. Galgano MT, Castle PE, Atkins KA, et al. Using biomarkers as objective standards in the diagnosis of cervical biopsies. Am J Surg Pathol 2010; 34: 1077-1087
22. Bergeron C, Ordi J, Schmidt D, et al. Conjunctive p16INK4a testing significantly increases accuracy in diagnosing high-grade cervical intraepithelial neoplasia. Am J Clin Pathol 2010; 133: 395-406
23. Klaes R, Benner A, Friedrich T, et al. p16INK4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia. Am J Surg Pathol 2002; 26: 1389-1399
24. Guedes AC, Brenna SM, Coelho SA, et al. p16(INK4a) expression does not predict the outcome of cervical intraepithelial neoplasia grade 2. Int J Gynecol Cancer 2007; 17: 1099-1103
25. Nishio S, Fujii T, Nishio H, et al. p16(INK4a) immunohistochemistry is a promising biomarker to predict the outcome of low grade cervical intraepithelial neoplasia: comparison study with HPV genotyping. J. Gynecol Oncol 2013; 24: 215-221
26. Razmpoosh M, Sansregret A, Oligny LL, et al. Assessment of correlation between p16INK4a staining, specific subtype of human papillomavirus, and progression of LSIL/CIN1 lesions: first comparative study. Am J Clin Pathol 2014; 142: 104-110
27. Youkeles L, Forsythe AB, Stern E. Evaluation of Papanicolaou smear and effect of sample biopsy in follow-up of cervical dysplasia. Cancer Res 1976; 36: 2080-2084